Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.

Abstract

We describe the case of a 56-year-old man who had high aminotransferase levels and anti-hepatitis C virus (HCV) antibodies. He underwent liver biopsy and biochemical screening to evaluate whether he would benefit from interferon (IFN) treatment. The patient was discharged with a diagnosis of HCV-related active chronic hepatitis, skin porphyria, and type 2… (More)

Topics

Cite this paper

@article{Borgia2001MyastheniaGD, title={Myasthenia gravis during low-dose IFN-alpha therapy for chronic hepatitis C.}, author={Guglielmo Borgia and Lucie Reynaud and I. Abbattista Gentile and Raimondo Cerini and R. Procesi Ciampi and Marika Dello Russo and Marcello Piazza}, journal={Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research}, year={2001}, volume={21 7}, pages={469-70} }